Spots Global Cancer Trial Database for Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer
Official Title:
Study ID: NCT02711865
Conditions
Study Description
Brief Summary: The main goal of this study is to employ a novel proteomic approach to identify predictive tumor biomarkers that will increase the efficacy of insulin-like growth factor (IGF1R) targeted therapy in epithelial ovarian cancer. It is expected that these predictive biomarkers will be applied to increase the response rate in selected groups of patients.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Hillel Yaffe Medical Center, Hadera, , Israel
Contact Details
Name: Ilan Bruchim, MD
Affiliation: Hillel Yaffe Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
